N-Acetyl Semax
Payment Options
N-Acetyl Semax 50 mg - Hilma Biocare
This modified synthetic neuropeptide is supplied as 50 mg of powder in one vial.
Manufacturer
Active substance
N-Acetyl Semax
Family
Synthetic neuropeptide
Form
Powder
Total content
50 mg
Packaging
1 vial
How It Works
It is a chemically modified form of the synthetic neuropeptide Semax. Research on the parent peptide has measured changes in neurotrophin gene expression, including BDNF related signalling in animal brain tissue. Acetylation changes the molecule’s properties, and a validated human mechanism for the acetylated preparation has not been established.
Focus and Cognitive Function Research
Interest centres on attention, cognition and responses to neurological stress. Most mechanistic claims come from studies of parent Semax rather than N-Acetyl Semax. Controlled human evidence does not establish improved training focus, motivation or recovery from this specific preparation.
- Investigating a modified Semax neuropeptide.
- Exploring neurotrophin related mechanisms identified with the parent compound.
- Examining how acetylation changes peptide behaviour.
Post Cycle Therapy
The peptide has no established androgen suppression mechanism or steroid PCT requirement. Human endocrine and withdrawal data for this exact derivative are limited, so no specific recovery protocol is established.
Side Effects
A reliable human adverse effect profile for N-Acetyl Semax has not been established. Hypersensitivity, local administration reactions and risks from impurities are possible. The effects of repeated exposure and interactions with other neuroactive substances remain insufficiently studied.










